Big Pharma is Not Interested in Helping People!'Given a worst-case scenario, the principals of Medivation have made themselves rich, even if they never produce a single product. If they do, then they'll become fabulously rich—even if their products produce only marginal benefits or do significant harm. Their positions within the corporation insulate them from most risk—a significantly different position from those who take their products in the hope of gaining some marginal benefit.
Think about it: The excitement over Dimebon relates to an improvement of 1.3 points over other drugs on a scale of 0-70 in the Alzheimer's Disease Assessment Scale, cognitive section—and there's no indication of arresting the disease.
For, at best, minimal benefit to patients, a small number of people who know how to play the system are, at a minimum, raking in millions on the hope of achieving that small gain. If they hit the jackpot, they stand to see profits in the tens or hundreds of millions of dollars.
Quite a scam, isn't it?'
Read more...
Related Post:
Widget by [ Iptek-4u ]
